PMC:7205724 / 607-1761 JSON TXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id	Subject	Object	Predicate	Lexical cue
T11	0-93	Sentence	denotes	The novel coronavirus, SARS-CoV2, can cause a potentially fatal disease, COVID-19, in humans.
T12	94-164	Sentence	denotes	Here, we will provide an overview of therapeutic options for COVID-19.
T13	165-314	Sentence	denotes	Plasma from patients recovered from COVID-19 that contains antibodies against SARS-CoV2 has shown promising results in patients with severe COVID-19.
T14	315-406	Sentence	denotes	Also, IVIG, combined with moderate-dose of corticosteroids, might improve patient outcomes.
T15	407-467	Sentence	denotes	Evidence links COVID-19 to variable degrees of inflammation.
T16	468-553	Sentence	denotes	Studies show that the use of corticosteroids might accelerate recovery from COVID-19.
T17	554-683	Sentence	denotes	There are, however, no controlled clinical trials that show whether the use of corticosteroids can reduce COVID-19-related death.
T18	684-859	Sentence	denotes	Also, the pro-inflammatory cytokine IL6 is the best-documented cytokine in COVID-19 correlated with severity, criticality, viral load, and prognosis of patients with COVID-19.
T19	860-971	Sentence	denotes	Tocilizumab, a monoclonal antibody against IL6, could confer clinical benefit in patients with high IL6 levels.
T20	972-1154	Sentence	denotes	Essential elements that process SARS-CoV2 cell entry and specific characteristics that allow SARS-CoV2 to escape the immune system have the potential as targets for COVID-19 therapy.